Here are the DEF 14A proxy statements from Royce Micro-Cap Trust Inc (RMT) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow RMT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RMT filings page.
Royce Micro-Cap Trust, Inc. is calling an Annual Meeting of stockholders for October 7, 2026, at its offices in New York. Stockholders of record at the close of business on August 5, 2026 are entitled to vote, with one vote per share of common stock.
The only proposal is to elect two Class III directors, Christopher D. Clark (interested director and President/CEO of the adviser) and Christopher C. Grisanti (lead independent director), each for a three-year term expiring at the 2029 annual meeting. The six-member Board currently includes five independent directors and oversees 15 portfolios in The Royce Funds complex.
The Audit Committee, made up entirely of independent directors, reviewed the 2025 audit by PricewaterhouseCoopers LLP and recommended inclusion of the audited financial statements in the 2025 annual report. Audit fees for 2025 were $43,490, and tax-related fees were $11,854. As of the record date, there were 54,191,506 shares outstanding; a Schedule 13D/A filing reports Saba Capital Management beneficially owning 3,786,726 shares, and a Schedule 13G filing reports Morgan Stanley beneficially owning 3,092,401 shares. Directors and officers as a group own less than 1% of shares. The Board recommends a vote in favor of all director nominees.